Is It Important to Adapt Neoadjuvant Chemotherapy to the...

The Oncologist 2015 / 03 Vol. 20; Iss. 3

Is It Important to Adapt Neoadjuvant Chemotherapy to the Visible Clinical Response? An Open Randomized Phase II Study Comparing Response-Guided and Standard Treatments in HER2-Negative Operable Breast Cancer

Wang-Lopez, Q., Mouret-Reynier, M.-A., Savoye, A.-M., Abrial, C., Kwiatkowski, F., Garbar, C., DuBray-Longeras, P., Eymard, J.-C., Lebouedec, G., Vanpraagh, I., Penault-Llorca, F., Chollet, P., Cure,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2014-0400
Date:
March, 2015
File:
PDF, 947 KB
english, 2015
Conversion to is in progress
Conversion to is failed